Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Global Forecast 2024-2030


Attention: There is an updated edition available for this report.

Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Global Forecast 2024-2030


The Vascular Graft Market size was estimated at USD 3.51 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 7.39% to reach USD 5.79 billion by 2030.

Global Vascular Graft Market

A vascular graft is a surgical process that redirects blood flow around a blocked or partially blocked artery in the heart by using a blood vessel taken from another part of your body, also known as a graft. Vascular grafts can be made from various materials, including synthetic polymers, such as polytetrafluoroethylene (PTFE) and polyurethane, and biological materials, such as collagen and human or animal tissue. The rise in the prevalence of vascular disorders and the rise in the geriatric population prone to cardiovascular diseases increases the adoption of vascular grafts. However, the risk of complications post-implantation of a vascular graft, such as graft infection and blood clots, may further hinder the adoption of the vascular graft. Nevertheless, the rise of biomaterial research for developing advanced, biocompatible grafts and the ongoing advancements in vascular imaging technologies such as 3D angiography offer potential for significant growth opportunities for the market.

Regional Insights

The vascular graft market is evolving in the Americas owing to technological advancements, rising healthcare expenditure, and the prevalence of cardiovascular disorders and diabetes in the region. Strong focus on regulatory compliance and safety measures, substantial research and development projects, increasing awareness regarding vascular grafts, and growing healthcare infrastructure encourage using vascular graft procedures to improve treatment outcomes in the EMEA region. Growing prevalence of lifestyle diseases and the accelerating expansion of healthcare services, significant medical technology advancements are resulting in the development of enhanced vascular graft procedures in the APAC region. Besides, the development of bioengineered vascular grafts that mimic the natural blood vessel structure and composition is anticipated to increase the use of this medical procedure by health professionals to treat various medical conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vascular Graft Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vascular Graft Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V..

Market Segmentation & Coverage

This research report categorizes the Vascular Graft Market to forecast the revenues and analyze trends in each of the following sub-markets:

Raw Material
Biological Materials
Human Saphenous & Umbilical Veins
Tissue Engineered Materials
Polyester
Polytetrafluoroethylene
Polyurethane
Product
Coronary Artery By-Pass Graft
Endovascular Stent Graft
Hemodialysis Access Graft
Peripheral Vascular Graft
Application
Aneurysm
Cardiovascular
Diabetes
Kidney Failure
Vascular Occlusion
End-User
Ambulatory Surgical Center
Hospital
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Vascular Graft Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vascular Graft Market?
3. What are the technology trends and regulatory frameworks in the Vascular Graft Market?
4. What is the market share of the leading vendors in the Vascular Graft Market?
5. Which modes and strategic moves are suitable for entering the Vascular Graft Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Vascular Graft Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lifestyle-related disorders globally
5.1.1.2. Growing preference for minimally invasive procedures
5.1.1.3. Rising number of clinical trials of vascular grafts
5.1.2. Restraints
5.1.2.1. High treatment cost of vascular graft procedures
5.1.3. Opportunities
5.1.3.1. Improvements in the design and performance of vascular grafts
5.1.3.2. Development of tissue-engineered vascular grafts
5.1.4. Challenges
5.1.4.1. Infections associated with vascular grafts
5.2. Market Segmentation Analysis
5.2.1. Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility
5.2.2. Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries
5.2.3. Application: Significant use of vascular grafts in treating cardiovascular diseases
5.2.4. End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Vascular Graft Market, by Raw Material
6.1. Introduction
6.2. Biological Materials
6.3.1. Human Saphenous & Umbilical Veins
6.3.2. Tissue Engineered Materials
6.3. Polyester
6.4. Polytetrafluoroethylene
6.5. Polyurethane
7. Vascular Graft Market, by Product
7.1. Introduction
7.2. Coronary Artery By-Pass Graft
7.3. Endovascular Stent Graft
7.4. Hemodialysis Access Graft
7.5. Peripheral Vascular Graft
8. Vascular Graft Market, by Application
8.1. Introduction
8.2. Aneurysm
8.3. Cardiovascular
8.4. Diabetes
8.5. Kidney Failure
8.6. Vascular Occlusion
9. Vascular Graft Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Hospital
10. Americas Vascular Graft Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Vascular Graft Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Vascular Graft Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
13.3.2. Investment & Funding
13.3.2.1. Xeltis’ aXess Vascular Graft Development Receives Funding From European Innovation Council
13.3.3. Award, Recognition, & Expansion
13.3.3.1. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Affluent Medical
14.1.3. B. Braun Melsungen AG
14.1.4. Becton, Dickinson and Company
14.1.5. BIOVIC Sdn. Bhd.
14.1.6. Boston Scientific Corporation
14.1.7. Cardinal Health Inc.
14.1.8. Cook Medical, Inc.
14.1.9. Corcym S.r.l.
14.1.10. CryoLife, Inc.
14.1.11. Endologix Inc.
14.1.12. Getinge AB
14.1.13. Heart Medical Europe B.V.
14.1.14. Japan Lifeline Co., Ltd.
14.1.15. Lemaitre Vascular, Inc.
14.1.16. Medtronic PLC
14.1.17. Merit Medical Systems, Inc.
14.1.18. Perouse Medical SAS by Vygon SAS
14.1.19. Rua Life Sciences PLC
14.1.20. Shanghai Suokang Medical Implants Co. Ltd.
14.1.21. Terumo Corporation
14.1.22. Vascular Graft Solutions Ltd.
14.1.23. VUP Medical
14.1.24. W. L. Gore & Associates, Inc.
14.1.25. Xeltis B.V.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. VASCULAR GRAFT MARKET RESEARCH PROCESS
FIGURE 2. VASCULAR GRAFT MARKET SIZE, 2023 VS 2030
FIGURE 3. VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VASCULAR GRAFT MARKET DYNAMICS
FIGURE 7. VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
FIGURE 8. VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings